ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,295Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1111

$1.69M Total Retail Price of All Prescriptions

Rank: 8 out of 1111

663 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 15,864 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 787 448 1 2
OMEPRAZOLE 775 444 2 4
FUROSEMIDE 715 526 3 6
AMLODIPINE BESYLATE 667 509 4 7
HYDROCODONE-ACETAMINOPHEN 662 401 S3 5 1
MELOXICAM 649 356 6 18
PRAVASTATIN SODIUM 534 381 7 17
CITALOPRAM HBR 485 328 8 14
TRAMADOL HCL 484 281 9 13
METOPROLOL TARTRATE 470 328 10 12
METFORMIN HCL 435 254 11 8
POTASSIUM CHLORIDE 405 295 12 9
LEVOTHYROXINE SODIUM 390 252 13 3
CARVEDILOL 358 278 14 21
RISPERIDONE 341 175 15 60
GABAPENTIN 329 200 16 10
FLUTICASONE PROPIONATE 323 188 17 27
SIMVASTATIN 314 181 18 5
NEXIUM 290 120 19 26
ZOLPIDEM TARTRATE 278 152 20 16
FENOFIBRATE 277 178 21 95
TRIAMTERENE-HCTZ 260 176 22 80
ISOSORBIDE MONONITRATE ER 226 173 23 73
KLOR-CON M20 220 159 24 79
DICLOFENAC SODIUM 218 114 25 108
SUCRALFATE 210 136 26 125
PREDNISONE 200 128 27 48
SERTRALINE HCL 200 104 27 24
HYDROCHLOROTHIAZIDE 198 110 29 11
SPIRIVA 197 112 30 53
ATORVASTATIN CALCIUM 191 147 31 15
TAMSULOSIN HCL 185 99 32 28
CLONIDINE HCL 183 95 33 42
CRESTOR 182 132 34 33
WARFARIN SODIUM 181 139 35 19
GEMFIBROZIL 176 112 36 92
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 121 37 23
ADVAIR DISKUS 172 104 38 43
ATENOLOL 170 125 39 22
BENZTROPINE MESYLATE 168 52 R 40 169
AMITRIPTYLINE HCL 166 103 R 41 64
METOPROLOL SUCCINATE 163 105 42 20
ACTOS 161 91 43 98
POLYETHYLENE GLYCOL 3350 160 97 44 45
TRAZODONE HCL 156 37 45 32
PANTOPRAZOLE SODIUM 152 109 46 50
PROAIR HFA 151 81 47 38
PROMETHAZINE HCL 145 81 R 48 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 144 99 49 71
LEVOFLOXACIN 143 82 50 88
RANITIDINE HCL 137 102 51 29
FLUOXETINE HCL 135 50 52 44
CYCLOBENZAPRINE HCL 132 28 R 53 37
HYDROXYZINE HCL 131 25 R 54 159
CIPROFLOXACIN HCL 126 98 55 58
NAMENDA 126 106 55 31
OXYBUTYNIN CHLORIDE 124 97 57 110
CLOPIDOGREL 120 89 58 30
CARBIDOPA-LEVODOPA 116 83 59 101
MECLIZINE HCL 115 75 60 162
NIASPAN 109 67 61 164
GLIPIZIDE 109 81 61 57
ABILIFY 109 33 61 123
TRICOR 109 59 61 157
OLANZAPINE 108 63 65 117
SINGULAIR 106 52 66 112
DONEPEZIL HCL 106 102 66 25
DOXYCYCLINE HYCLATE 106 47 66 113
METHOCARBAMOL 103 41 R 69 159
AZITHROMYCIN 101 76 70 39
ALLOPURINOL 97 78 71 36
LEVEMIR 97 78 71 132
TOPIRAMATE 96 35 73 177
GLYBURIDE 96 45 R 73 59
PLAVIX 96 75 73 49
QUETIAPINE FUMARATE 96 31 73 76
PAROXETINE HCL 91 40 77 55
DIOVAN 91 74 77 51
MIRTAZAPINE 88 47 79 52
LITHIUM CARBONATE 86 0 80 250
VALPROIC ACID 86 0 80 249
LOVASTATIN 86 60 80 41
ALENDRONATE SODIUM 85 73 83 35
FENTANYL 85 35 S2 83 65
TIZANIDINE HCL 84 24 85 91
LANTUS 84 56 85 46
ROPINIROLE HCL 82 69 87 68
METOCLOPRAMIDE HCL 79 36 88 130
TORSEMIDE 78 64 89 118
PHENYTOIN SODIUM EXTENDED 77 11 90 126
SEROQUEL XR 77 18 90 237
ENALAPRIL MALEATE 76 41 92 56
VERAPAMIL ER 76 53 92 100
SPIRONOLACTONE 76 46 92 83
DIGOXIN 75 65 95 47
TRIAMCINOLONE ACETONIDE 74 62 96 128
SYMBICORT 72 24 97 176
VENTOLIN HFA 72 42 97 122
DICYCLOMINE HCL 71 43 99 225
DIVALPROEX SODIUM 71 35 99 82
AMLODIPINE BESYLATE-BENAZEPRIL 71 66 99 67
ETODOLAC 69 18 102 137
LYRICA 69 0 102 62
LIPITOR 67 47 104 116
CARBAMAZEPINE 66 11 105 196
DIOVAN HCT 66 54 105 94
NYSTATIN 65 44 107 151
MUPIROCIN 65 41 107 154
KETOCONAZOLE 64 35 109 314
AMOX TR-POTASSIUM CLAVULANATE 63 43 110 141
MONTELUKAST SODIUM 62 39 111 206
ALBUTEROL SULFATE 62 53 111 136
CLOZAPINE 61 0 113 181
RISPERDAL CONSTA 61 13 113 350
FLUCONAZOLE 59 35 115 195
HALOPERIDOL 58 0 116 180
PIOGLITAZONE HCL 57 38 R 117 269
LEVETIRACETAM 57 35 117 111
OXYBUTYNIN CHLORIDE ER 57 34 117 114
XOPENEX HFA 54 11 120 283
METOLAZONE 52 47 121 162
LOVAZA 52 26 121 184
INVEGA SUSTENNA 52 12 121 325
IBUPROFEN 51 22 124 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.